Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges.

Avard D, Bridge P, Bucci LM, Chiquette J, Dorval M, Durocher F, Easton D, Godard B, Goldgar D, Knoppers BM, Laframboise R, Lespérance B, Plante M, Tavtigian SV, Vézina H, Wilson B; INHERIT BRCAs, Simard J.

Fam Cancer. 2006;5(1):3-13. Review.

PMID:
16528603
2.

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.

Antoniou AC, Durocher F, Smith P, Simard J, Easton DF; INHERIT BRCAs program members.

Breast Cancer Res. 2006;8(1):R3. Epub 2005 Dec 12.

3.

Genetics of breast cancer: applications to the Mexican population.

Ziv E.

Salud Publica Mex. 2011 Sep-Oct;53(5):415-9. Review.

4.

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.

Meindl A; German Consortium for Hereditary Breast and Ovarian Cancer.

Int J Cancer. 2002 Feb 1;97(4):472-80.

5.

[Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].

Narod SA, Rodríguez AA.

Salud Publica Mex. 2011 Sep-Oct;53(5):420-9. Review. Spanish.

6.

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.

J Clin Oncol. 2002 Jun 1;20(11):2701-12.

PMID:
12039933
7.

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T.

Int J Cancer. 2002 Feb 1;97(4):466-71.

8.

Ethical implications of genetic testing for breast cancer susceptibility.

Surbone A.

Crit Rev Oncol Hematol. 2001 Nov;40(2):149-57. Review.

PMID:
11682322
9.

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.

Fackenthal JD, Olopade OI.

Nat Rev Cancer. 2007 Dec;7(12):937-48. Review.

PMID:
18034184
10.

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.

Yassaee VR, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi MA, Hornby DP, Dalton A.

Breast Cancer Res. 2002;4(4):R6. Epub 2002 Apr 16.

11.

[Genetic predisposition to breast and ovarian cancer: importance of test results].

Julian-Reynier C.

Med Sci (Paris). 2011 Jun-Jul;27(6-7):657-61. doi: 10.1051/medsci/2011276019. Epub 2011 Jul 1. Review. French.

12.

Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.

Chang-Claude J, Becher H, Caligo M, Eccles D, Evans G, Haites N, Hodgson S, Møller P, Weber BH, Stoppa-Lyonnet D.

Dis Markers. 1999 Oct;15(1-3):53-65.

13.

Breast Cancer: Genetics and Risk Assessment.

Tejada-Bergés T.

Clin Obstet Gynecol. 2016 Dec;59(4):673-687. Review.

PMID:
27749364
14.
15.
16.

Costs and benefits of diagnosing familial breast cancer.

Heimdal K, Maehle L, Møller P.

Dis Markers. 1999 Oct;15(1-3):167-73.

17.

Hereditary gynecologic cancers: risk assessment, counseling, testing and management.

Ballinger LL.

Obstet Gynecol Clin North Am. 2012 Jun;39(2):165-81. doi: 10.1016/j.ogc.2012.02.006. Review.

PMID:
22640709
18.

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.

American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins--Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists.

Obstet Gynecol. 2009 Apr;113(4):957-66. doi: 10.1097/AOG.0b013e3181a106d4.

PMID:
19305347
19.

Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy.

Rouleau I, Chiquette J, Plante M, Simard J, Dorval M.

J Obstet Gynaecol Can. 2004 Dec;26(12):1059-66.

PMID:
15607041
20.

The future of DNA diagnostics.

Skolnick MH.

Dis Markers. 1999 Oct;15(1-3):106-7. No abstract available.

Supplemental Content

Support Center